505 related articles for article (PubMed ID: 7870229)
1. Analysis of platelet abnormalities in uremia with and without Glanzmann's thrombasthenia.
Nomura S; Hamamoto K; Kawakatsu T; Kido H; Yamaguchi K; Fukuroi T; Suzuki M; Yanabu M; Shouzu A; Nishikawa M
Nephron; 1994; 68(4):442-8. PubMed ID: 7870229
[TBL] [Abstract][Full Text] [Related]
2. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
3. Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation.
Stricker RB; Wong D; Shiu DT; Reyes PT; Shuman MA
Blood; 1986 Jul; 68(1):275-80. PubMed ID: 2941084
[TBL] [Abstract][Full Text] [Related]
4. [Glanzmann's thrombasthenia: a rare example of an integrin deficit].
Perutelli P; Mori PG
Recenti Prog Med; 1992 Oct; 83(10):577-81. PubMed ID: 1462042
[TBL] [Abstract][Full Text] [Related]
5. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
[TBL] [Abstract][Full Text] [Related]
6. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
Fournier DJ; Kabral A; Castaldi PA; Berndt MC
Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
[TBL] [Abstract][Full Text] [Related]
7. Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation.
Grainick HR; Williams SB; Coller BS
J Clin Invest; 1985 Jan; 75(1):19-25. PubMed ID: 2981249
[TBL] [Abstract][Full Text] [Related]
8. A variant of Glanzmann's thrombasthenia which fails to express a GPIIb-IIIa related epitope that is recognized by a specific monoclonal antibody (C17).
Escolar G; Diaz-Ricart M; Garrido M; Reverter JC; Villamor N; Sanz C; Maragall S; Castillo R; Ordinas A; Nurden AT
Br J Haematol; 1992 Aug; 81(4):545-51. PubMed ID: 1382548
[TBL] [Abstract][Full Text] [Related]
9. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
[TBL] [Abstract][Full Text] [Related]
10. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran.
Farsinejad A; Farajollahi MM; Kazemi A; Saemi N; Faranoush M
Blood Coagul Fibrinolysis; 2013 Sep; 24(6):613-8. PubMed ID: 23912132
[TBL] [Abstract][Full Text] [Related]
11. A Cys374Tyr homozygous mutation of platelet glycoprotein IIIa (beta 3) in a Chinese patient with Glanzmann's thrombasthenia.
Grimaldi CM; Chen F; Scudder LE; Coller BS; French DL
Blood; 1996 Sep; 88(5):1666-75. PubMed ID: 8781422
[TBL] [Abstract][Full Text] [Related]
12. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M
Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579
[TBL] [Abstract][Full Text] [Related]
13. Studies of the platelet fibrinogen receptor in Glanzmann patients and uremic patients.
Lindahl TL; Lundahl J; Netré C; Egberg N
Thromb Res; 1992 Aug; 67(4):457-66. PubMed ID: 1412224
[TBL] [Abstract][Full Text] [Related]
14. Classification of Iranian patients with Glanzmann's Thrombasthenia using a flow cytometric method.
Farsinejad A; Abolghasemi H; Kazemi A; Aghaiipour M; Hadjati E; Faranoush M; Jazebi M; Ala F
Platelets; 2011; 22(5):321-7. PubMed ID: 21526886
[TBL] [Abstract][Full Text] [Related]
15. A new case of acquired Glanzmann's thrombasthenia: diagnostic value of flow cytometry.
Giannini S; Mezzasoma AM; Guglielmini G; Rossi R; Falcinelli E; Gresele P
Cytometry B Clin Cytom; 2008 May; 74(3):194-9. PubMed ID: 18200593
[TBL] [Abstract][Full Text] [Related]
16. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL
Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089
[TBL] [Abstract][Full Text] [Related]
17. Glanzmann's thrombasthenia: updated.
Nair S; Ghosh K; Kulkarni B; Shetty S; Mohanty D
Platelets; 2002 Nov; 13(7):387-93. PubMed ID: 12487785
[TBL] [Abstract][Full Text] [Related]
18. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
Salvati F; Liani M
Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay.
Disdier M; Legrand C; Bouillot C; Dubernard V; Pidard D; Nurden AT
Thromb Res; 1989 Mar; 53(6):521-33. PubMed ID: 2499944
[TBL] [Abstract][Full Text] [Related]
20. A variant of Glanzmann's thrombasthenia with abnormal glycoprotein IIb-IIIa complexes in the platelet membrane.
Nurden AT; Rosa JP; Fournier D; Legrand C; Didry D; Parquet A; Pidard D
J Clin Invest; 1987 Mar; 79(3):962-9. PubMed ID: 3818957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]